Answers are grounded in this paper and cite their sources.
Indigenous women in the Peruvian Amazon are underrepresented in cervical cancer research. We characterized cervical cytology and human papillomavirus (HPV) genotypes in 90 clinical records from a source population described as Awajún, Kichwa, and Shawi women; individual community affiliation was unavailable. This cross-sectional secondary analysis linked cytology and Allplex HPV28 results within participant records. No normal cytology reports were represented. Cytology-report groups comprised unspecified squamous atypia or low-grade-compatible findings (68.9%), high-grade-compatible or glandular abnormalities (5.6%), and unspecified cytology (25.6%). HPV was detected in 39 women (43.3%; 95% confidence interval [CI]: 33.6–53.6%). Among HPV-positive women, 41.0% had coinfections; 92.3% (95% CI: 79.7–97.3%) carried study-defined high/probably high-risk genotypes, whereas 76.9% carried an International Agency for Research on Cancer (IARC) Group 1 genotype. HPV-68 was the most frequently detected genotype, occurring in seven HPV-positive women (17.9%; 95% CI: 9.0–32.7%). In exploratory analyses, no statistically significant association was detected between cytology-report grouping and study-defined high/probably high-risk HPV detection (p = 0.156; Cramér’s V = 0.209) or IARC Group 1 detection (p = 0.191). Individual molecular internal-control and histological follow-up data were unavailable. These findings cannot establish population prevalence, screening performance, or prevention gaps. Larger studies with standardized cytology and follow-up are needed.
No takes yet. Share an insight, caveat, or question.
Panduro-Boyer et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: